Compounds for treatment of intractable epilepsy and doors syndrome

Patrick Verstreken (Uitvinder), Kevin Lüthy (Uitvinder), Wim Versées (Uitvinder), Baptiste Fischer (Uitvinder), Jone Paesmans (Uitvinder)

Onderzoeksoutput: Patent

Samenvatting

The present invention relates to the field of neurodegenerative diseases, and the prevention and/or treatment of TBC1D24-associated disorders, such as DOORS syndrome, (intractable) epilepsy, and nonsyndromic deafness. In particular, the present invention relates to phosphoinositide phosphatase inhibitors and screening methods for producing such inhibitors, more particularly, Synaptojanin-1 5' phosphatase inhibitors, to increase phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) levels in neuronal cells.
Originele taal-2English
OctrooinummerEP3503880
StatusPublished - 2019

Vingerafdruk

Duik in de onderzoeksthema's van 'Compounds for treatment of intractable epilepsy and doors syndrome'. Samen vormen ze een unieke vingerafdruk.

Citeer dit